跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,324 条关于
“Haystack MRD”
全部
7,324
临床试验
5,766
药物
598
机构
161
资讯
799
5个月前
City of Hope Launches Multi-Cancer Study of Quest Diagnostics' Haystack MRD Test Across 14 Sites
去年
Mass General Brigham Launches Clinical Trials for Haystack MRD ctDNA Test in Head and Neck and Skin Cancers
7个月前
Quest Diagnostics Launches Noninvasive Blood Test for Multiple Myeloma Residual Disease Monitoring
4个月前
Minimal Residual Disease Pipeline Set for Strategic Expansion by 2026 with Emerging Immunotherapies and Precision Diagnostics
去年
Immunotherapy Alone Successfully Treats Multiple Cancer Types with MMRd Mutation, Eliminating Need for Surgery
去年
Haystack Project Advocates for Alternative Trial Designs in Rare Disease Drug Approvals
2年前
Telo Genomics Evaluates MRD Assay in Multiple Myeloma with TELO-DMRD Study
2年前
Daratumumab-Based Regimens Deepen Responses and Improve MRD Negativity in Multiple Myeloma
2年前
FDA Panel Endorses Minimal Residual Disease (MRD) as Endpoint for Accelerated Approval in Multiple Myeloma
11年前
Pre-Transplant MRD Positivity Linked to Poorer Survival in Acute Leukemia Patients
第 1 页,共 80 页
上一页
下一页